Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,919,225)	$ (985,857)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	3,388	9,572
Amortization of intangibles	13,426	11,352
Stock based compensation	305,370	113,507
Employees paid in stock	164,385	115,000
Non-cash operating lease expense	(17,378)	1,883
Deferred profit and divesture-equity investment (See Note 6)	0	(1,301)
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(120,341)	101,895
(Increase) in accounts receivable, related party	(269,973)	(267,300)
(Decrease) increase in inventories	(258,395)	399,630
Decrease (Increase) in advances on contracts	92,007	(338,995)
(Increase) in prepaid expenses and other current assets	(246,720)	(272,905)
Increase in accounts payable	231,668	211,072
Increase (decrease) in accounts payable, related party	733,062	(200,778)
(Decrease) increase in accrued expenses	(81,797)	339,518
Decrease in accrued expenses, related party	(156,427)	(204,107)
Decrease operating right of use lease liability	19,442	0
Net cash used in operating activities	(1,507,508)	(967,814)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	0	(5,916)
Net cash used in investing activities	0	(5,916)
Cash flows from financing activities:
Proceeds from exercise of warrants	0	3,012,216
Payments finance lease obligations	(2,063)	(1,883)
Common stock issued to employee for option exercised	0	690,190
Net cash (used in) provided by financing activities	(2,063)	3,700,523
Net (decrease) increase in cash and cash equivalents	(1,509,571)	2,726,793
Cash and cash equivalents at beginning of period	14,764,346	14,223,917
Cash and cash equivalents at end of period	$ 13,254,775	$ 16,950,710